VP, Chief Accounting Officer
Disclosures on record
10
Companies involved
1
Stock since the trade +20.8% · S&P 500 +6.8% · to Oct 1Traded 4 days after resultsStock within 3% of its 52-week high, after a 28% rise in the previous month
2,418.81 → 1,522.81 shares held−37% of their stake
West Pharmaceutical Services's VP, Chief Accounting Officer sold $269K of West Pharmaceutical Services shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
